BIAF Stock Rises Post Q1 Earnings Despite Revenue Decline

• click to rate

  Posted by Two Blokes May 20, 2025 - Filed in Stock - 4 views
  
  bioAffinity's first-quarter 2025 results show CyPath Lung sales growth and cost cuts despite a drop in total revenues and a wider quarterly net loss.